Lintao Wang Selected Research

Lintao Wang Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 09/2005
9	Inflammation (Inflammations) 01/2018 - 09/2015
7	Wounds and Injuries (Trauma) 01/2018 - 09/2015
7	Fibrosis (Cirrhosis) 12/2017 - 09/2015
6	Obesity 12/2017 - 11/2015
3	Hyperglycemia 03/2019 - 10/2015
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 04/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2015
2	Atherosclerosis 07/2018 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 12/2017 - 04/2016
1	Necrosis 11/2022
1	Liver Diseases (Liver Disease) 11/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022
1	Bites and Stings (Sting) 01/2021
1	Cardiotoxicity 01/2021
1	Diarrhea 01/2021
1	Insulinoma 03/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Atherosclerotic Plaque (Atheroma) 07/2018
1	Hypertrophy 01/2018
1	Fibrosarcoma 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Proteinuria 12/2017
1	Sepsis (Septicemia) 08/2017
1	Lung Injury 08/2017
1	Silicosis 01/2017
1	Vascular Remodeling 01/2017
1	Diabetic Cardiomyopathies 04/2016
1	Diabetes Complications 10/2015

Drug/Important Bio-Agent (IBA)

7	Immunoconjugates (Immunoconjugate)IBA 10/2019 - 09/2005
4	CytokinesIBA 01/2018 - 10/2015
4	Palmitic Acid (Hexadecanoic Acid)IBA 01/2018 - 11/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 09/2005
3	LipidsIBA 07/2018 - 12/2017
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2016
3	Ado-Trastuzumab EmtansineIBA 01/2017 - 09/2005
2	Silicon Dioxide (Silica)FDA LinkGeneric 11/2022 - 01/2017
2	Angiotensin IIIBA 01/2022 - 04/2016
2	InterferonsIBA 01/2022 - 01/2021
2	Insulin (Novolin)FDA Link 03/2019 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 10/2015
2	LipopolysaccharidesIBA 12/2017 - 08/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2017 - 01/2017
2	ApolipoproteinsIBA 01/2017 - 04/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 09/2015
2	Chalcone (Benzalacetophenone)IBA 11/2015 - 10/2015
2	Maytansine (Maitansine)IBA 06/2015 - 07/2006
1	Epidermal Growth Factor (EGF)IBA 11/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2022
1	C-Reactive ProteinIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	MineralsIBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	ClayIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Toll-Like Receptor 2IBA 01/2021
1	SmectiteIBA 01/2021
1	ribosomal protein L32IBA 01/2020
1	Biological ProductsIBA 01/2020
1	exatecan (DX 8951f)IBA 10/2019
1	Blood Glucose (Blood Sugar)IBA 03/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2018
1	AcidsIBA 07/2018
1	kaempferolIBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	PlasticsIBA 01/2018
1	ChromatinIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Staphylococcal Protein A (Protein A)IBA 01/2018
1	PolymersIBA 12/2017
1	Becaplermin (PDGF-BB)FDA Link 12/2017
1	GelatinIBA 12/2017
1	CreatinineIBA 12/2017
1	Brentuximab VedotinIBA 01/2017
1	AMP-Activated Protein KinasesIBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	EndotoxinsIBA 11/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2016
1	Apolipoproteins E (ApoE)IBA 04/2016
1	RTKI cpdIBA 04/2016
1	Mitogen-Activated Protein KinasesIBA 11/2015
1	AntigensIBA 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 10/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2015
1	Cell Adhesion MoleculesIBA 10/2015
1	PalmitatesIBA 09/2015
1	imidazopyridineIBA 09/2015
1	osthol (osthole)IBA 04/2015

Therapy/Procedure

4	Therapeutics 01/2019 - 09/2005
2	Oral Administration 01/2021 - 10/2015
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2021
1	Tissue Transplantation 11/2022
1	Immunotherapy 01/2021
1	Islets of Langerhans Transplantation 03/2019